Fund Evaluator:
iShares Large Cap Moderate Qt Ldrd ETF (IVVM)
Follow This Fund
Equity
Global Asset Class
Nontraditional Equity
Fund Group
Defined Outcome
Category
$0.000
NAV (as of )
$0.00
Minimum Initial
0.50% A
Expense Ratio
$175 Mil
Assets
Open
Status
na
12b-1 Fee
0.58%
TTM Yield
0.00%
Max Load
0%
Portfolio Turnover
Best Performing in Defined Outcome Over the Last Year
| 13.0% | Vest US Large Cap 10% Buffer Strats Inv (BUMGX) |
| 8.6% | Vest US Large Cap 20% Buffer Strats Inv (ENGLX) |
Data as of 7/31/2026
0.5% C
1-Mo Return
2.7% C
3-Mo Return
6.9% B
YTD Return
13.4% B
1-Yr Return
13.5% B
3-Yr Return
na
5-Yr Return
0.95 C
Category Risk Index
0.58
Total Risk Index
Fund Details
Fund Family
BlackRock
Inception Date
6/28/2023
Share Class Type
Equity Investment Style
Large-Cap
Blend
Bond Investment Style
na
Socially Responsible Fund
No
Index Fund
No
Benchmark Index
S&P 500 (TR) (1970): 100%
Additional Fund Details
iShares Large Cap Moderate Qt Ldrd ETF Overview
IVVM Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| IVVM Return (NAV) | 0.5% | 2.7% | 13.4% | 13.5% | na | na |
| IVVM Grade | C | C | B | B | na | na |
| +/- Category | 0.2% | 0.3% | 2.7% | 2.8% | na | na |
| Defined Outcome Avg | 0.3% | 2.3% | 10.8% | 10.6% | 7.8% | na |
| IVVM Tax Cost Ratio | na | na | 0.3% | 0.2% | na | na |
IVVM Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| IVVM Return (NAV) | 6.9% | 14.1% | 16.3% | na | na | na | na | na | na | na | na |
| IVVM Grade | B | A | B | na | na | na | na | na | na | na | na |
| +/- Category | 1.3% | 4.2% | 3.6% | na | na | na | na | na | na | na | na |
| Defined Outcome Avg | 5.6% | 9.9% | 12.7% | 16.2% | -8.3% | 13.6% | 11.7% | 23.9% | -4.9% | 15.1% | na |
| Risk Measures | |
| Standard Deviation: | 7.1% |
| Total Risk Index: | 0.58 - Below Average |
| Category Risk Index: | 0.95 - Average |
| Category Risk Grade: | C (45% Rank) |
| Beta: | 0.52 |
| R-Squared: | 94% |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Large-Cap Blend |
| Bond Investment Style: | na |
| Yield: | 0.6% |
| Dividend Distribution: | Annually |
| Cap Gains Distribution: | Annually |
| Total Assets: | $175 Mil |
| Fund Total Assets: | $ 175 Mil |
| Share Class Type: | |
| Portfolio Turnover: | 0% |
Management Team
| Number of Managers: 2 | |||
| Longest Tenure: 3.1 years | |||
| Average Tenure: 1.9 years | |||
| Managers (Year): McClements Kyle (2023), Armstrong Erin (2025) | |||
Portfolio Composition (as of 7/31/26)
| # of Holdings: | 15 |
| % in Top 10 Holdings: | 184.8% |
| Fund is Non-Diversified: | No |
| % in Foreign Issues: | 0.3% |
Portfolio Allocation |
|
| Domestic Stock: | 55.4% |
| Foreign Stock: | 0.3% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.0% |
| Cash: | 44.3% |
Purchase Information
| Fund Family: | BlackRock |
| Phone Number: | 800-474-2737 |
| Website: |
| Status: | Open |
| Inception Date: | June 28, 2023 |
| Min. Initial Purchase: | $ 0 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | na |
Expenses and Fees | |
| Expense Ratio (%): | 0.50% ( Rating : Avg ) |
| Category Average Expense Ratio (%): | 1.20% |
| Share Class: | iShares Large Cap Moderate Qt Ldrd ETF |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
Copyright 2026 American Association of Individual Investors and Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.